Positive effect of natalizumab on depression, as assessed by BDI-II scores in the SENTINEL Trial

Authors
Category Primary study
ConferenceAnnals of Neurology
Year 2016
This article has no abstract
Epistemonikos ID: 1c695b7d438118f69b06299e7b975ffb1dc73847
First added on: Apr 29, 2026